Rat-anti-CC1 antibody
Host Species: Rat
Important Notice: Antigen retrieval is recommended before IHC/IF-Fr staining.
Gene Synonyms: Oligodendrocyte-specific antibody, Clone CC1, QKI7
Species Reactivity: Mouse, Rat; Predict to work in primates
Applications: IF/IHC-Fr: 1:100~300
Antigen Retrieval: For an alternative approach, tissue sections could be incubated in 1x Citrate antigen retrieval solution for 30 min at 95°C and cool down to room temperature before next procedure.
Important Notice: When used in the CNS tissues of neonatal mice, astrocytes and OPCs with weak CC1 expression should be excluded from mature oligodendrocyte population based on their morphology, gene expression level and tissue distribution.
Immunogen: Synthetic peptide conjugated with KLH
Purification: Affinity purification
General Notes: FOR RESEARCH USE ONLY
Storage Buffer: pH7.4, PBS, 50mM Tris, 50mM Glycine, ~40% Glycerol, 0.1% potassium sorbate
Storage: Shipped at 4°C. Store at -20°C/4°C for months and -80°C for years. Avoid freeze/thaw cycle
Background: Few markers exist that specifically label mature oligodendrocyte cell bodies in the central nervous system without labeling myelin. Thus, when staining for oligodendrocytes, the cell bodies typically are masked by the abundant surrounding myelin, making them difficult to identify or precisely count. The monoclonal antibody anti-adenomatous polyposis coli (APC) clone CC1, hereafter referred to as the CC1 antibody, is the most common tool used to specifically detect mature oligodendrocytes without labeling myelin. However, previous studies showed that the CC1 antibody does not bind APC [1-3]. As an antibody recognizing the cytoplasmic isoform QKI7 proteins, CC1 is a useful and reliable marker for counting the number of mature oligodendrocytes in postnatal animals (older than P15 in the brain and P7 in the spinal cord) [3, 4]. When used in the CNS tissues of neonatal mice, astrocytes and OPCs with weak CC1 expression should be excluded from mature oligodendrocyte population based on their morphology, gene expression level and tissue distribution.
[1] Brakeman JS, et al. Neuroscience. 1999. DIO: 10.1016/s0306-4522(98)00605-8.
[2] Bhat RV, et al. J Neurosci. 1994. DIO: 10.1523/JNEUROSCI.14-05-03059.1994.
[3] Bin JM, et al. J Neurochem. 2016. DIO: 10.1111/jnc.13745.
[4] Takeuchi A, et al. Stem Cell Reports. 2020. DIO: 10.1016/j.stemcr.2020.08.010.
Key Words: oligodendrocytes, mature oligodendrocytes, myelin, myelinating oligodendrocytes